What Is ALT (Alanine Aminotransferase)? Normal vs Optimal Range Explained

The lab upper limit of 56 U/L was established decades ago using reference populations that unknowingly included people with early fatty liver disease—a condition that now affects roughly 25–30 percent of adults worldwide. This contaminated reference pool inflated the "normal" ceiling, hiding genuine liver stress behind a falsely reassuring number. The CTD maps 1,650 compounds that interact with ALT gene expression, demonstrating how sensitive this enzyme is to chemical exposures, medications, and metabolic disruptions. Annals of Internal Medicine (PMID 12093239) recalculated healthy upper limits by excluding donors with hepatitis C and metabolic syndrome, arriving at significantly lower thresholds. The American College of Gastroenterology now recommends sex-specific upper limits of 33 U/L for men and 25 U/L for women, acknowledging that liver fat accumulation and insulin resistance begin well below the traditional cutoff. An ALT of 40 in a man with a growing waistline is not "fine"—it is an early signal of fatty liver.

Non-alcoholic fatty liver disease (NAFLD) is the number one cause of chronically elevated ALT and the most common liver disease globally. PubMed indexes over 95,000 publications on ALT, with meta-analyses consistently showing that each 10 U/L rise in ALT above the optimal range increases the risk of type 2 diabetes by 10–15 percent and cardiovascular disease by 5–10 percent. FAERS data document ALT elevation as a reported adverse event for over 300 medications, including statins, anticonvulsants, NSAIDs, antifungals, and antipsychotics. The clinical significance of elevated ALT depends heavily on context: an acute spike above 1,000 U/L suggests viral hepatitis or drug toxicity, while a chronic modest elevation in the 30–80 range points to metabolic fatty liver or slow-burning autoimmune hepatitis.

Very low ALT—below 7 U/L—can also carry meaning that is frequently overlooked. ALT requires vitamin B6 (pyridoxal-5-phosphate) as an essential cofactor, and without adequate B6 the enzyme cannot function at full catalytic capacity, so severe B6 deficiency can produce misleadingly low ALT readings that mask ongoing liver damage. This is particularly relevant in patients on isoniazid (which directly depletes B6 through pyridoxine antagonism) or in elderly patients with poor nutritional status and reduced intestinal absorption. The optimal 10–25 U/L band represents a liver under minimal stress: hepatocytes are not being damaged by fat accumulation, medications, or chronic inflammation, and B6 cofactor supply is adequate to maintain normal enzymatic function. Trend matters more than any single number—a rising ALT over three to six months deserves investigation with ultrasound and metabolic workup even if each individual value stays below the traditional lab flag.